BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9137296)

  • 1. Valsartan for hypertension.
    Med Lett Drugs Ther; 1997 Apr; 39(999):43-4. PubMed ID: 9137296
    [No Abstract]   [Full Text] [Related]  

  • 2. Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy.
    Kondrack R; Mohiuddin S
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1125-34. PubMed ID: 19689218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
    Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aliskiren/valsartan (Valturna) for hypertension.
    Med Lett Drugs Ther; 2009 Nov; 51(1326):94-5. PubMed ID: 20224524
    [No Abstract]   [Full Text] [Related]  

  • 5. [New combination of high dosage sartan and 25 mg HCT. Systolic blood pressure lowered by 21 mmHg].
    MMW Fortschr Med; 2004 Apr; 146(15):68. PubMed ID: 15373029
    [No Abstract]   [Full Text] [Related]  

  • 6. [New prospects in the treatment of arterial hypertension. Antagonist of angiotensin II valsartan (diovan)].
    Ivleva AIa
    Ter Arkh; 1998; 70(9):85-8. PubMed ID: 9821238
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double profit for hypertensive patients. Blood pressure decreases--frequency of coitus increases].
    MMW Fortschr Med; 2003 Aug; 145(33-34):56. PubMed ID: 14526578
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sartans for lowering blood pressure. Hypertensive patients need not fear potency].
    MMW Fortschr Med; 2002 Apr; 144(17):48. PubMed ID: 12048853
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
    Scholze J; Müller U
    MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertension.
    Blumer J; Batisky DL; Wells T; Shi V; Solar-Yohay S; Sunkara G
    J Clin Pharmacol; 2009 Feb; 49(2):235-41. PubMed ID: 19179299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valsartan. Just a second-line antihypertensive drug.
    Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AT1 receptor antagonists in treatment of hypertension].
    Franz IW
    Fortschr Med; 1997 Jul; 115(19):38-40. PubMed ID: 9333581
    [No Abstract]   [Full Text] [Related]  

  • 16. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men.
    Fogari R; Preti P; Derosa G; Marasi G; Zoppi A; Rinaldi A; Mugellini A
    Eur J Clin Pharmacol; 2002 Jun; 58(3):177-80. PubMed ID: 12107602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer].
    Unger T
    Fortschr Med; 1997 Aug; 115(24):42-3. PubMed ID: 9410822
    [No Abstract]   [Full Text] [Related]  

  • 20. [The hypotensive effect and tolerance of valsartan (Diovan) in hypertension in a general clinical practice].
    Ivleva AIa; Sokolova MA; Moiseev VS
    Ter Arkh; 1999; 71(2):67-70. PubMed ID: 10222559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.